Yvonne Greenstreet, CEO of Alnylam Pharmaceuticals ($ALNY), made 83 open market sales of company shares over the past year, totaling $43.2 million. Her most recent sale occurred on March 4, 2026. These sales rank 369th among 11,678 individual insiders by total value sold, well above the average of $8.6 million per insider and 6.4 transactions. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 4, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 368 | $321.82 | 98,129.0000 | 134,684,000 | 0.37% | 0.00% |
| March 4, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 274 | $320.81 | 98,497.0000 | 134,684,000 | 0.28% | 0.00% |
| March 4, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 129 | $320.01 | 98,771.0000 | 134,684,000 | 0.13% | 0.00% |
| March 4, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 135 | $319.03 | 98,900.0000 | 134,684,000 | 0.14% | 0.00% |
| March 4, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 265 | $325.67 | 96,102.0000 | 134,684,000 | 0.27% | 0.00% |
| March 4, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 345 | $324.88 | 96,367.0000 | 134,684,000 | 0.36% | 0.00% |
| March 4, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 973 | $323.84 | 96,712.0000 | 134,684,000 | 1.00% | 0.00% |
| March 4, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 444 | $323.01 | 97,685.0000 | 134,684,000 | 0.45% | 0.00% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 1399 | $327.67 | 101,086.0000 | 134,684,000 | 1.37% | 0.00% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 1669 | $326.81 | 102,485.0000 | 134,684,000 | 1.60% | 0.00% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 1098 | $325.63 | 104,154.0000 | 134,684,000 | 1.04% | 0.00% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 382 | $324.65 | 105,252.0000 | 134,684,000 | 0.36% | 0.00% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | A | Common Stock | 13844 | $0.00 | 105,834.0000 | 134,684,000 | 15.05% | 0.01% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 200 | $323.62 | 105,634.0000 | 134,684,000 | 0.19% | 0.00% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | A | Stock Price Performance Stock Unit | 110746 | $0.00 | 110,746.0000 | 134,684,000 | 9999.99% | 0.08% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | A | Stock Option (right to buy) | 30425 | $0.00 | 30,425.0000 | 134,684,000 | 9999.99% | 0.02% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 160 | $332.64 | 99,035.0000 | 134,684,000 | 0.16% | 0.00% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 399 | $331.93 | 99,195.0000 | 134,684,000 | 0.40% | 0.00% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 346 | $330.85 | 99,594.0000 | 134,684,000 | 0.35% | 0.00% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 722 | $329.71 | 99,940.0000 | 134,684,000 | 0.72% | 0.00% |
| March 2, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 424 | $328.71 | 100,662.0000 | 134,684,000 | 0.42% | 0.00% |
| Feb. 27, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | M | Restricted Stock Units | 5921 | $0.00 | 0.0000 | 134,684,000 | 100.00% | 0.00% |
| Feb. 27, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | M | Common Stock | 5921 | $0.00 | 91,990.0000 | 134,684,000 | 6.88% | 0.00% |
| Feb. 13, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 6958 | $310.08 | 86,069.0000 | 134,684,000 | 7.48% | 0.01% |
| Feb. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | A | Common Stock | 14209 | $0.00 | 93,027.0000 | 134,684,000 | 18.03% | 0.01% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 253 | $369.48 | 79,257.0000 | 134,684,000 | 0.32% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 94 | $377.82 | 78,818.0000 | 134,684,000 | 0.12% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 118 | $375.65 | 78,912.0000 | 134,684,000 | 0.15% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 88 | $374.44 | 79,030.0000 | 134,684,000 | 0.11% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 21 | $372.46 | 79,118.0000 | 134,684,000 | 0.03% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 118 | $370.87 | 79,139.0000 | 134,684,000 | 0.15% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 584 | $368.62 | 79,510.0000 | 134,684,000 | 0.73% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 261 | $367.40 | 80,094.0000 | 134,684,000 | 0.32% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 316 | $366.41 | 80,355.0000 | 134,684,000 | 0.39% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 1395 | $365.56 | 80,671.0000 | 134,684,000 | 1.70% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 1259 | $364.83 | 82,066.0000 | 134,684,000 | 1.51% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 301 | $363.55 | 83,325.0000 | 134,684,000 | 0.36% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 464 | $362.38 | 83,626.0000 | 134,684,000 | 0.55% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 624 | $361.45 | 84,090.0000 | 134,684,000 | 0.74% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 980 | $360.22 | 84,714.0000 | 134,684,000 | 1.14% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 537 | $359.14 | 85,694.0000 | 134,684,000 | 0.62% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 778 | $358.18 | 86,231.0000 | 134,684,000 | 0.89% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 607 | $357.17 | 87,009.0000 | 134,684,000 | 0.69% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 263 | $356.09 | 87,616.0000 | 134,684,000 | 0.30% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 269 | $355.16 | 87,879.0000 | 134,684,000 | 0.31% | 0.00% |
| Jan. 12, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 247 | $353.95 | 88,148.0000 | 134,684,000 | 0.28% | 0.00% |
| Jan. 11, 2026 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | A | Common Stock | 19003 | $0.00 | 88,395.0000 | 134,684,000 | 27.39% | 0.01% |
| Nov. 26, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | M | Common Stock | 2352 | $85.00 | 69,007.0000 | 137,348,000 | 3.53% | 0.00% |
| Nov. 26, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | M | Common Stock | 839 | $119.13 | 66,655.0000 | 137,348,000 | 1.27% | 0.00% |
| Nov. 26, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | M | Stock Option (right to buy) | 659 | $0.00 | 28,141.0000 | 137,348,000 | 2.29% | 0.00% |
| Nov. 26, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | M | Stock Option (right to buy) | 839 | $0.00 | 0.0000 | 137,348,000 | 100.00% | 0.00% |
| Nov. 26, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | M | Stock Option (right to buy) | 847 | $0.00 | 0.0000 | 137,348,000 | 100.00% | 0.00% |
| Nov. 26, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | M | Stock Option (right to buy) | 2352 | $0.00 | 0.0000 | 137,348,000 | 100.00% | 0.00% |
| Nov. 26, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | F | Common Stock | 1121 | $445.12 | 69,392.0000 | 137,348,000 | 1.59% | 0.00% |
| Nov. 26, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | M | Common Stock | 659 | $151.59 | 70,513.0000 | 137,348,000 | 0.94% | 0.00% |
| Nov. 26, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | M | Common Stock | 847 | $118.05 | 69,854.0000 | 137,348,000 | 1.23% | 0.00% |
| Nov. 13, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 2218 | $450.69 | 70,454.0000 | 137,348,000 | 3.05% | 0.00% |
| Nov. 12, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | M | Common Stock | 650 | $42.22 | 66,466.0000 | 137,348,000 | 0.99% | 0.00% |
| Nov. 13, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 1477 | $450.02 | 72,672.0000 | 137,348,000 | 1.99% | 0.00% |
| Nov. 13, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 1013 | $448.76 | 74,149.0000 | 137,348,000 | 1.35% | 0.00% |
| Nov. 13, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 654 | $447.73 | 75,162.0000 | 137,348,000 | 0.86% | 0.00% |
| Nov. 13, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | M | Common Stock | 10000 | $119.13 | 75,816.0000 | 137,348,000 | 15.19% | 0.01% |
| Nov. 12, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 430 | $458.42 | 65,816.0000 | 137,348,000 | 0.65% | 0.00% |
| Nov. 12, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 604 | $457.71 | 66,246.0000 | 137,348,000 | 0.90% | 0.00% |
| Nov. 12, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 2420 | $456.64 | 66,850.0000 | 137,348,000 | 3.49% | 0.00% |
| Nov. 12, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 3406 | $455.56 | 69,270.0000 | 137,348,000 | 4.69% | 0.00% |
| Nov. 12, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 1960 | $454.84 | 72,676.0000 | 137,348,000 | 2.63% | 0.00% |
| Nov. 12, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 1069 | $453.52 | 74,636.0000 | 137,348,000 | 1.41% | 0.00% |
| Nov. 12, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 1210 | $452.43 | 75,705.0000 | 137,348,000 | 1.57% | 0.00% |
| Nov. 12, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 1255 | $451.16 | 76,915.0000 | 137,348,000 | 1.61% | 0.00% |
| Nov. 12, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 453 | $450.17 | 78,170.0000 | 137,348,000 | 0.58% | 0.00% |
| Nov. 12, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 2132 | $449.15 | 78,623.0000 | 137,348,000 | 2.64% | 0.00% |
| Nov. 12, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | M | Common Stock | 15000 | $119.13 | 81,466.0000 | 137,348,000 | 22.57% | 0.01% |
| Nov. 12, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 711 | $448.07 | 80,755.0000 | 137,348,000 | 0.87% | 0.00% |
| Nov. 13, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | M | Performance Stock Option 2017 (right to buy) | 10000 | $0.00 | 0.0000 | 137,348,000 | 100.00% | 0.01% |
| Nov. 12, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | M | Performance Stock Option 2017 (right to buy) | 15000 | $0.00 | 10,000.0000 | 137,348,000 | 60.00% | 0.01% |
| Nov. 12, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | M | Performance Stock Option 2016 (right to buy) | 650 | $0.00 | 0.0000 | 137,348,000 | 100.00% | 0.00% |
| Nov. 13, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 261 | $456.03 | 65,816.0000 | 137,348,000 | 0.39% | 0.00% |
| Nov. 13, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 195 | $454.69 | 66,077.0000 | 137,348,000 | 0.29% | 0.00% |
| Nov. 13, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 881 | $453.99 | 66,272.0000 | 137,348,000 | 1.31% | 0.00% |
| Nov. 13, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 1599 | $452.85 | 67,153.0000 | 137,348,000 | 2.33% | 0.00% |
| Nov. 13, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 1702 | $451.94 | 68,752.0000 | 137,348,000 | 2.42% | 0.00% |
| Oct. 1, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | A | Common Stock | 14252 | $0.00 | 74,740.0000 | 137,348,000 | 23.56% | 0.01% |
| Oct. 1, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | A | Common Stock | 3860 | $0.00 | 60,488.0000 | 137,348,000 | 6.82% | 0.00% |
| Oct. 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 350 | $446.53 | 74,390.0000 | 137,348,000 | 0.47% | 0.00% |
| Oct. 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 171 | $447.92 | 74,219.0000 | 137,348,000 | 0.23% | 0.00% |
| Oct. 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 548 | $448.77 | 73,671.0000 | 137,348,000 | 0.74% | 0.00% |
| Oct. 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 758 | $449.79 | 72,913.0000 | 137,348,000 | 1.03% | 0.00% |
| Oct. 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 1642 | $450.81 | 71,271.0000 | 137,348,000 | 2.25% | 0.00% |
| Oct. 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 1010 | $451.86 | 70,261.0000 | 137,348,000 | 1.42% | 0.00% |
| Oct. 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 2029 | $452.69 | 68,232.0000 | 137,348,000 | 2.89% | 0.00% |
| Oct. 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 999 | $453.77 | 67,233.0000 | 137,348,000 | 1.46% | 0.00% |
| Oct. 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 741 | $454.84 | 66,492.0000 | 137,348,000 | 1.10% | 0.00% |
| Oct. 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 221 | $455.82 | 66,271.0000 | 137,348,000 | 0.33% | 0.00% |
| Oct. 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 446 | $457.43 | 65,825.0000 | 137,348,000 | 0.67% | 0.00% |
| Oct. 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 9 | $457.64 | 65,816.0000 | 137,348,000 | 0.01% | 0.00% |
| Aug. 15, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | A | Common Stock | 14252 | $0.00 | 63,607.0000 | 127,651,000 | 28.88% | 0.01% |
| Aug. 18, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 2716 | $454.04 | 57,892.0000 | 127,651,000 | 4.48% | 0.00% |
| Aug. 18, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 1646 | $452.96 | 60,608.0000 | 127,651,000 | 2.64% | 0.00% |
| Aug. 18, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 60 | $455.82 | 56,628.0000 | 127,651,000 | 0.11% | 0.00% |
| Aug. 18, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 514 | $451.99 | 62,254.0000 | 127,651,000 | 0.82% | 0.00% |
| Aug. 18, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 195 | $450.92 | 62,768.0000 | 127,651,000 | 0.31% | 0.00% |
| Aug. 18, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 450 | $449.92 | 62,963.0000 | 127,651,000 | 0.71% | 0.00% |
| Aug. 18, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 194 | $447.98 | 63,413.0000 | 127,651,000 | 0.30% | 0.00% |
| Aug. 18, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 1204 | $454.84 | 56,688.0000 | 127,651,000 | 2.08% | 0.00% |
| May 30, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | M | Stock Option (right to buy) | 12081 | $0.00 | 12,919.0000 | 127,651,000 | 48.32% | 0.01% |
| May 30, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | M | Common Stock | 12081 | $119.13 | 61,436.0000 | 127,651,000 | 24.48% | 0.01% |
| June 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | M | Stock Option (right to buy) | 12080 | $0.00 | 839.0000 | 127,651,000 | 93.51% | 0.01% |
| May 30, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 25469 | $304.00 | 55,526.0000 | 127,651,000 | 31.45% | 0.02% |
| May 30, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 6171 | $306.00 | 49,355.0000 | 127,651,000 | 11.11% | 0.00% |
| May 30, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | M | Common Stock | 19559 | $118.05 | 80,995.0000 | 127,651,000 | 31.84% | 0.02% |
| June 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | M | Common Stock | 12080 | $119.13 | 61,435.0000 | 127,651,000 | 24.48% | 0.01% |
| June 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | M | Common Stock | 7217 | $118.05 | 68,652.0000 | 127,651,000 | 11.75% | 0.01% |
| June 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 19297 | $306.00 | 49,355.0000 | 127,651,000 | 28.11% | 0.02% |
| May 30, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | M | Stock Option (right to buy) | 19559 | $0.00 | 8,064.0000 | 127,651,000 | 70.81% | 0.02% |
| June 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | M | Stock Option (right to buy) | 7217 | $0.00 | 847.0000 | 127,651,000 | 89.50% | 0.01% |
| May 16, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | G | Common Stock | 8376 | $0.00 | 49,355.0000 | 127,651,000 | 14.51% | 0.01% |
| May 2, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | G | Common Stock | 41311 | $0.00 | 57,731.0000 | 127,651,000 | 41.71% | 0.03% |
| March 3, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | A | Common Stock | 17965 | $0.00 | 102,919.0000 | 127,651,000 | 21.15% | 0.01% |
| March 3, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 1068 | $242.37 | 101,851.0000 | 127,651,000 | 1.04% | 0.00% |
| March 3, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 1173 | $243.36 | 100,678.0000 | 127,651,000 | 1.15% | 0.00% |
| March 3, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 791 | $244.41 | 99,887.0000 | 127,651,000 | 0.79% | 0.00% |
| March 3, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 580 | $245.26 | 99,307.0000 | 127,651,000 | 0.58% | 0.00% |
| March 3, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 238 | $246.18 | 99,069.0000 | 127,651,000 | 0.24% | 0.00% |
| March 3, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 23 | $247.35 | 99,046.0000 | 127,651,000 | 0.02% | 0.00% |
| March 3, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 4 | $248.36 | 99,042.0000 | 127,651,000 | 0.00% | 0.00% |
| March 3, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | A | Stock Option (right to buy) | 36293 | $0.00 | 36,293.0000 | 127,651,000 | 9999.99% | 0.03% |
| Feb. 27, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | M | Common Stock | 5921 | $0.00 | 87,854.0000 | 127,651,000 | 7.23% | 0.00% |
| Feb. 28, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 158 | $236.51 | 87,696.0000 | 127,651,000 | 0.18% | 0.00% |
| Feb. 28, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 123 | $238.33 | 87,573.0000 | 127,651,000 | 0.14% | 0.00% |
| Feb. 28, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 127 | $239.18 | 87,446.0000 | 127,651,000 | 0.15% | 0.00% |
| Feb. 28, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 284 | $240.32 | 87,162.0000 | 127,651,000 | 0.32% | 0.00% |
| Feb. 28, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 461 | $241.51 | 86,701.0000 | 127,651,000 | 0.53% | 0.00% |
| Feb. 28, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 1093 | $242.44 | 85,608.0000 | 127,651,000 | 1.26% | 0.00% |
| Feb. 28, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 440 | $243.23 | 85,168.0000 | 127,651,000 | 0.51% | 0.00% |
| Feb. 28, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 214 | $244.11 | 84,954.0000 | 127,651,000 | 0.25% | 0.00% |
| Feb. 27, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | M | Restricted Stock Units | 5921 | $0.00 | 5,921.0000 | 127,651,000 | 50.00% | 0.00% |
| Feb. 14, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 47 | $257.51 | 82,144.0000 | 127,651,000 | 0.06% | 0.00% |
| Feb. 14, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 25 | $264.87 | 81,933.0000 | 127,651,000 | 0.03% | 0.00% |
| Feb. 14, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 21 | $263.33 | 81,958.0000 | 127,651,000 | 0.03% | 0.00% |
| Feb. 14, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 47 | $261.45 | 81,979.0000 | 127,651,000 | 0.06% | 0.00% |
| Feb. 14, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 38 | $260.57 | 82,026.0000 | 127,651,000 | 0.05% | 0.00% |
| Feb. 14, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 21 | $259.72 | 82,064.0000 | 127,651,000 | 0.03% | 0.00% |
| Feb. 14, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 59 | $258.07 | 82,085.0000 | 127,651,000 | 0.07% | 0.00% |
| Feb. 14, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 98 | $256.29 | 82,191.0000 | 127,651,000 | 0.12% | 0.00% |
| Feb. 14, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 85 | $255.56 | 82,289.0000 | 127,651,000 | 0.10% | 0.00% |
| Feb. 14, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 201 | $254.35 | 82,374.0000 | 127,651,000 | 0.24% | 0.00% |
| Feb. 14, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 300 | $253.37 | 82,575.0000 | 127,651,000 | 0.36% | 0.00% |
| Feb. 14, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 271 | $252.50 | 82,875.0000 | 127,651,000 | 0.33% | 0.00% |
| Feb. 13, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | A | Common Stock | 3859 | $0.00 | 83,146.0000 | 127,651,000 | 4.87% | 0.00% |
| Nov. 26, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 93 | $247.77 | 84,413.0000 | 128,590,000 | 0.11% | 0.00% |
| Nov. 26, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 762 | $249.60 | 83,651.0000 | 128,590,000 | 0.90% | 0.00% |
| Nov. 26, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 1131 | $250.68 | 82,520.0000 | 128,590,000 | 1.35% | 0.00% |
| Nov. 26, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 2933 | $251.42 | 79,587.0000 | 128,590,000 | 3.55% | 0.00% |
| Nov. 26, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 300 | $252.27 | 79,287.0000 | 128,590,000 | 0.38% | 0.00% |
| Nov. 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | A | Common Stock | 10658 | $0.00 | 84,506.0000 | 128,590,000 | 14.43% | 0.01% |
| Aug. 20, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | M | Common Stock | 15000 | $85.00 | 88,848.0000 | 124,906,000 | 20.31% | 0.01% |
| Aug. 20, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 15000 | $280.00 | 73,848.0000 | 124,906,000 | 16.88% | 0.01% |
| Aug. 20, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | M | Stock Option (right to buy) | 15000 | $0.00 | 2,352.0000 | 124,906,000 | 86.45% | 0.01% |
| Aug. 1, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | M | Common Stock | 15148 | $85.00 | 88,996.0000 | 124,906,000 | 20.51% | 0.01% |
| Aug. 1, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 15148 | $270.00 | 73,848.0000 | 124,906,000 | 17.02% | 0.01% |
| Aug. 1, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | M | Stock Option (right to buy) | 15148 | $0.00 | 17,352.0000 | 124,906,000 | 46.61% | 0.01% |
| July 11, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 7093 | $261.00 | 73,848.0000 | 124,906,000 | 8.76% | 0.01% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 1374 | $229.06 | 86,558.0000 | 124,906,000 | 1.56% | 0.00% |
| June 24, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | A | Common Stock | 16953 | $0.00 | 89,242.0000 | 124,906,000 | 23.45% | 0.01% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 308 | $221.71 | 88,934.0000 | 124,906,000 | 0.35% | 0.00% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 66 | $224.17 | 88,868.0000 | 124,906,000 | 0.07% | 0.00% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 93 | $225.55 | 88,775.0000 | 124,906,000 | 0.10% | 0.00% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 177 | $226.82 | 88,598.0000 | 124,906,000 | 0.20% | 0.00% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 666 | $228.30 | 87,932.0000 | 124,906,000 | 0.75% | 0.00% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 1572 | $229.93 | 84,986.0000 | 124,906,000 | 1.82% | 0.00% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 511 | $231.59 | 84,475.0000 | 124,906,000 | 0.60% | 0.00% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 1119 | $232.54 | 83,356.0000 | 124,906,000 | 1.32% | 0.00% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 595 | $233.53 | 82,761.0000 | 124,906,000 | 0.71% | 0.00% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 957 | $234.66 | 81,804.0000 | 124,906,000 | 1.16% | 0.00% |
| June 25, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 863 | $235.19 | 80,941.0000 | 124,906,000 | 1.05% | 0.00% |
| March 1, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | A | Stock Option (right to buy) | 46394 | $0.00 | 46,394.0000 | 124,906,000 | 9999.99% | 0.04% |
| March 1, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | A | Common Stock | 23754 | $0.00 | 72,289.0000 | 124,906,000 | 48.94% | 0.02% |
| Feb. 28, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 588 | $156.38 | 48,627.0000 | 124,906,000 | 1.19% | 0.00% |
| Feb. 28, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 84 | $157.30 | 48,543.0000 | 124,906,000 | 0.17% | 0.00% |
| Feb. 28, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 8 | $158.09 | 48,535.0000 | 124,906,000 | 0.02% | 0.00% |
| Feb. 27, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | M | Restricted Stock Units | 5921 | $0.00 | 11,842.0000 | 124,906,000 | 33.33% | 0.00% |
| Feb. 28, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 1259 | $154.54 | 50,208.0000 | 124,906,000 | 2.45% | 0.00% |
| Feb. 28, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 993 | $155.45 | 49,215.0000 | 124,906,000 | 1.98% | 0.00% |
| Feb. 27, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | M | Common Stock | 5921 | $0.00 | 51,467.0000 | 124,906,000 | 13.00% | 0.00% |
| Feb. 16, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 840 | $149.03 | 45,546.0000 | 124,906,000 | 1.81% | 0.00% |
| Feb. 16, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 2576 | $147.50 | 50,000.0000 | 124,906,000 | 4.90% | 0.00% |
| Feb. 15, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | A | Common Stock | 16953 | $0.00 | 52,576.0000 | 124,906,000 | 47.59% | 0.01% |
| Feb. 16, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Greenstreet Yvonne | Chief Executive Officer | S | Common Stock | 3614 | $148.24 | 46,386.0000 | 124,906,000 | 7.23% | 0.00% |